Korro Bio IncKRRO
Price$9.71

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.4M+4.9% YoYTTM through 30 Jun 2026
Net Income -$106.6MTTM through 30 Jun 2026
Free Cash Flow -$68.3MTTM through 30 Jun 2026

Margins

Current
Gross Margin0.0%
Operating Margin-4,625.5%
Net Margin-4,477.1%

Returns

-16.4%ROE
-10.7%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.88x
Net Debt-$157.1Mnet cash position
Cash & Equivalents$24.9M

Quality Metrics

Altman Z-Score-3.52
Piotroski F-Score3 / 9
FCF Margin-2,865.9%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'23'24'25
FY2025: $6.4M
Diluted EPS-$9.88TTM
'22'23'24'25
FY2025: $-12.48

Dividend

No dividend

Capital Allocation

Capex Intensity13.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.